Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6307
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms ; volume:24 ; number:10 ; day:21 ; month:7 ; year:2022 ; pages:310-320 ; date:10.2022
Current rheumatology reports ; 24, Heft 10 (21.7.2022), 310-320, 10.2022
- Creator
-
Tam, Hoi Ki Joshua
Robinson, Philip C.
Nash, Peter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11926-022-01084-4
- URN
-
urn:nbn:de:101:1-2022113021103113804802
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tam, Hoi Ki Joshua
- Robinson, Philip C.
- Nash, Peter
- SpringerLink (Online service)
Other Objects (12)
Rheumatic disease
Rheumatic Heart Disease in Children
Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease
Rheumatic heart disease: infectious disease origin, chronic care approach
Human antibody therapeutics for viral disease
Recent developments in Alzheimer's disease therapeutics
Review: Microbial Therapeutics for Liver Disease
Next generation therapeutics for Alzheimer's disease
Splicing therapeutics for A lzheimer's disease
Vasculitis, rheumatic disease, and the nervous system
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Diagnostic value of salivary CRP and IL-6 in patients undergoing anti-TNF-alpha therapy for rheumatic disease
Rheumatic disease
Rheumatic Heart Disease in Children
Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease
Rheumatic heart disease: infectious disease origin, chronic care approach
Human antibody therapeutics for viral disease
Recent developments in Alzheimer's disease therapeutics
Review: Microbial Therapeutics for Liver Disease
Next generation therapeutics for Alzheimer's disease
Splicing therapeutics for A lzheimer's disease
Vasculitis, rheumatic disease, and the nervous system
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Diagnostic value of salivary CRP and IL-6 in patients undergoing anti-TNF-alpha therapy for rheumatic disease
Rheumatic disease
Rheumatic Heart Disease in Children
Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease
Rheumatic heart disease: infectious disease origin, chronic care approach
Human antibody therapeutics for viral disease
Recent developments in Alzheimer's disease therapeutics
Review: Microbial Therapeutics for Liver Disease
Next generation therapeutics for Alzheimer's disease
Splicing therapeutics for A lzheimer's disease
Vasculitis, rheumatic disease, and the nervous system
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?